This company listing is no longer active
Algorae Pharmaceuticals Gestione
Gestione criteri di controllo 1/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
David Hainsworth
Amministratore delegato
AU$40.0k
Compenso totale
| Percentuale dello stipendio del CEO | 100.0% |
| Mandato del CEO | 1.8yrs |
| Proprietà del CEO | 1.2% |
| Durata media del management | 1yrs |
| Durata media del Consiglio di amministrazione | 1.8yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$2m |
| Sep 30 2023 | n/a | n/a | -AU$2m |
| Jun 30 2023 | AU$40k | AU$40k | -AU$2m |
Compensazione vs Mercato: David's total compensation ($USD27.09K) is below average for companies of similar size in the German market ($USD505.12K).
Compensazione vs guadagni: Insufficient data to compare David's compensation with company performance.
AMMINISTRATORE DELEGATO
David Hainsworth (50 yo)
1.8yrs
Mandato
AU$40,000
Compensazione
Mr. David Richard Hainsworth is an Associate Director with Alignment Capital, principally focused on the origination and execution of primarily Australian Stock Exchange based capital market transactions w...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Chairman | no data | AU$40.00k | 1.19% € 112.0k | |
| Chief Financial Officer | 5.3yrs | AU$153.71k | Nessun dato | |
| Chief Operations Officer | 2.6yrs | AU$182.95k | Nessun dato | |
| Member of Medical Advisory Board & Chief Medical Officer of NTCELL | less than a year | AU$50.00k | 0.067% € 6.3k | |
| Chief Scientific Officer | 1.1yrs | Nessun dato | Nessun dato | |
| Company Secretary | less than a year | Nessun dato | Nessun dato | |
| Company Secretary | no data | Nessun dato | Nessun dato |
1.0yrs
Durata media
Gestione esperta: LHI1's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Executive Chairman | 1.8yrs | AU$40.00k | 1.19% € 112.0k | |
| Member of Medical Advisory Board & Chief Medical Officer of NTCELL | no data | AU$50.00k | 0.067% € 6.3k | |
| Non-Executive Director | less than a year | Nessun dato | 1.19% € 112.0k | |
| Non-executive Director | 1.8yrs | AU$33.33k | 1.19% € 112.0k |
1.8yrs
Durata media
55.5yo
Età media
Consiglio di amministrazione esperto: LHI1's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.